Filter Results:
(51)
Show Results For
- All HBS Web
(76)
- News (14)
- Research (51)
- Multimedia (1)
- Faculty Publications (29)
Show Results For
- All HBS Web
(76)
- News (14)
- Research (51)
- Multimedia (1)
- Faculty Publications (29)
Sort by
- February 2015
- Case
Longbow Capital Partners
By: Malcolm Baker, Samuel G. Hanson and James Weber
Longbow Capital Partners is a value-oriented long/short hedge fund focused on stocks in the energy sector. In January 2011, Longbow had invested in NiSource, a Fortune 500 company that owns a diverse portfolio of regulated energy businesses. In late 2014, Longbow was... View Details
Keywords: Value Investing; Investment Strategy; Dividend Yield; Intrinsic Value; Dividend Discount Model; Master Limited Partnership; Hedge Fund; Energy Industry; Regulation; Utilities; Finance; Financial Services Industry; United States
Baker, Malcolm, Samuel G. Hanson, and James Weber. "Longbow Capital Partners." Harvard Business School Case 215-026, February 2015.
- October 2005
- Case
Tad Piper and Piper Jaffray
By: William W. George and Andrew N. McLean
In 2005, Tad Piper reflects on the successful spin-off from US Bancorp of Piper Jaffray, the investment bank founded by his grandfather. Profiles the development of Piper Jaffray from a Midwestern brokerage house to a national, diversified financial services firm. In... View Details
Keywords: Crisis Management; Leadership Style; Management Style; Leadership; Growth and Development Strategy; Financial Services Industry
George, William W., and Andrew N. McLean. "Tad Piper and Piper Jaffray." Harvard Business School Case 406-033, October 2005.
- February 2015 (Revised November 2015)
- Case
Building an Integrated Biopharma Company: Crucell (A)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Biotechnology Industry; Pharmaceutical Industry; Netherlands
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
- March 2022
- Supplement
Transforming Kimball International, Inc. (B)
By: Lynn S. Paine and Will Hurwitz
Supplements the (A) case. View Details
Keywords: Board Of Directors; Board Committees; Board Decisions; Board Dynamics; CEO Compensation; CEO Succession; Compensation Committee; Compensation Consultants; Compensation Design; Compensation Mix; Corporate Purpose; COVID-19; ESG; Furniture; Furniture Industry; Manufacturing; Midwest; Pandemic; Purpose; Spin-off; Strategic Change; Strategic Decisions; Strategic Evolution; Target-setting; Executive Compensation; Family Ownership; Governance; Restructuring; Strategy; Transformation; Manufacturing Industry; United States
Paine, Lynn S., and Will Hurwitz. "Transforming Kimball International, Inc. (B)." Harvard Business School Supplement 322-084, March 2022.
- January 2018
- Case
Blue Harbour's Activism at Babcock & Wilcox
By: Suraj Srinivasan and Quinn Pitcher
The case describes Blue Harbour Group's investment in Babcock & Wilcox and its transformation into BWX Technologies. In 2004, activist hedge fund Blue Harbour Group invested in Babcock & Wilcox, an energy and construction company. Blue Harbour developed an investment... View Details
Keywords: Corporate Governance; Investment Activism; Leading Change; Energy Industry; Construction Industry; United States
Srinivasan, Suraj, and Quinn Pitcher. "Blue Harbour's Activism at Babcock & Wilcox." Harvard Business School Case 118-045, January 2018.
- January 2020 (Revised July 2020)
- Case
Chemours (A)
By: David G. Fubini and David Lane
The July 2015 spin-off of DuPont’s performance chemicals division as the independent company Chemours burdened new CEO Mark Vergnano and his team with perilous challenges. Despite market-leading offerings in several areas, the company faced a glutted market for its... View Details
Keywords: Transformation; Chemicals; Leading Change; Crisis Management; Organizational Change and Adaptation; Chemical Industry; United States
Fubini, David G., and David Lane. "Chemours (A)." Harvard Business School Case 420-001, January 2020. (Revised July 2020.)
- April 2017 (Revised May 2017)
- Case
GE Capital After the Crisis
By: John C. Coates, John D. Dionne and David S. Scharfstein
Keith Sherin, CEO of GE Capital, faced a decision on which hinged billions of dollars and the fate of one of America’s most storied companies. On his desk sat two secret analyses: Project Beacon, a proposal to spin off most of GE Capital to GE shareholders, and... View Details
Coates, John C., John D. Dionne, and David S. Scharfstein. "GE Capital After the Crisis." Harvard Business School Case 217-071, April 2017. (Revised May 2017.)
- July 2002 (Revised December 2002)
- Case
Mercer Management Consulting (A)
By: Thomas J. DeLong and Michael Echenberg
Insurance giant Marsh & McLennan acquires management consulting firms Temple, Barker & Sloane (TBS) in 1987 and Strategic Planning Associates (SPA) in 1990 and sets out to merge the two. The merger proceeds slowly and painfully. Following the February 1990 merger,... View Details
Keywords: Mergers and Acquisitions; Business Model; Decision Making; Organizational Culture; Personal Development and Career; Horizontal Integration; Consulting Industry
DeLong, Thomas J., and Michael Echenberg. "Mercer Management Consulting (A)." Harvard Business School Case 403-009, July 2002. (Revised December 2002.)
- 13 Nov 2012
- First Look
First Look: November 13
executives who were at Olympus while the scandal occurred. Purchase this supplement:http://hbr.org/search/413075-PDF-ENG Brink's Company: Activists Push for a Spin-off Suraj Srinivasan, Aldo Sesia, and Amy KaserHarvard Business School... View Details
Keywords: Sean Silverthorne
- 01 Oct 2001
- Research & Ideas
How To Make Restructuring Work for Your Company
hospital business and a health insurance business, management decided to split the businesses apart through a corporate spin-off because it realized the businesses were strategically incompatible—the customers of one business were... View Details
Keywords: by Stuart C. Gilson
- 10 Jan 2005
- Research & Ideas
Professors Introduce Valuation Software
In an age when mergers, acquisitions, and spin-offs are increasingly common in business, you need a new skill in your kit bag: the ability to analyze and value potential partners, deals, investments—even your own company. The Business... View Details
Keywords: by Sean Silverthorne
- 07 Apr 2015
- First Look
First Look: April 7
https://cb.hbsp.harvard.edu/cbmp/product/515043-PDF-ENG Harvard Business School Case 215-001 Project Titan at Northrop Grumman In March of 2011, Northrop Grumman divested shipbuilding assets through the spin-off of Huntington Ingalls... View Details
Keywords: Sean Silverthorne
- 09 Jun 2003
- Research & Ideas
The Benefits of “Not Invented Here”
include higher growth for one's own business, through incorporating additional ideas into the business. Another benefit is higher profits from one's ideas, through licensing and spin-off ventures that turn underused technology into... View Details
Keywords: by Sean Silverthorne
- 16 Jun 2015
- First Look
First Look: June 16, 2015
815-085 Building an Integrated Biopharma Company: Crucell (A) By 2009, Crucell had become the largest biopharma company in the Netherlands and was a symbol of national pride. The case traces the evolution of the company from a university View Details
Keywords: Sean Silverthorne
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
and the page description language that evolved into Adobe. But since the company's sights were then fixed on its copier and large-systems printer businesses, Xerox missed the opportunity to take advantage of its scientists' genius. Instead, to the View Details
Keywords: by Jim Aisner
- 26 Feb 2007
- Research & Ideas
The Power of the Noncompete Clause
fewer risks for fear of making mistakes and thus losing their job? Also of interest to us is whether companies adjust their strategies based on noncompete enforcement. We might expect, for example, that unsanctioned spin-offs will... View Details
Keywords: by Martha Lagace
- 17 Oct 2011
- Research & Ideas
How ‘Hybrid’ Nonprofits Can Stay on Mission
as spin-offs from existing NGOs. Both set out to avoid mission drift. But each took a different tack in hiring new employees. BancoSol hired employees based on their previous experience and proven capabilities. Because the mission... View Details
Keywords: by Carmen Nobel
- 01 Oct 2001
- Research & Ideas
Five Questions for Stuart Gilson
business opportunity. For example, in an equity spin-off, a diversified firm's businesses are split apart into independent entities, each with its own common stock. Spin-offs can make sense when a high-growth business is being held back... View Details
Keywords: by Sean Silverthorne
- 06 Feb 2007
- First Look
First Look: February 6, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=806092 Endo Pharmaceuticals (A): From LBO to...? Harvard Business School Case 806-064 Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck.... View Details
Keywords: Martha Lagace
- 18 Mar 2001
- Research & Ideas
Want to Be an Entrepreneur? [Part I]
already." Such is the pace of business development that "Starting New Ventures" has spawned its own spin-off this year, a separate course focused on launching technology ventures. That has let Hart's class focus more on... View Details
Keywords: by John S. Rosenberg